These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35390795)

  • 1. Adult Height of Patients with SHOX Haploinsufficiency with or without GH Therapy: A Real-World Single-Center Study.
    Dantas NCB; Funari MFA; Vasques GA; Andrade NLM; Rezende RC; Brito V; Scalco RC; Arnhold IJP; Mendonca BB; Jorge AAL
    Horm Res Paediatr; 2022; 95(3):264-274. PubMed ID: 35390795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.
    Ogata T; Onigata K; Hotsubo T; Matsuo N; Rappold G
    Endocr J; 2001 Jun; 48(3):317-22. PubMed ID: 11523902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height.
    Dotremont H; France A; Heinrichs C; Tenoutasse S; Brachet C; Cools M; De Waele K; Massa G; Lebrethon MC; Gies I; Van Besien J; Derycke C; Ziraldo M; De Schepper J; Beauloye V; Verhulst S; Rooman R; den Brinker M
    Front Endocrinol (Lausanne); 2023; 14():1113750. PubMed ID: 37008942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of SHOX haploinsufficiency among short statured children.
    Marstrand-Joergensen MR; Jensen RB; Aksglaede L; Duno M; Juul A
    Pediatr Res; 2017 Feb; 81(2):335-341. PubMed ID: 27814343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature.
    Wang W; Wang Y; Xiao Y; Cao N; Wang Y
    BMC Pediatr; 2023 Dec; 23(1):615. PubMed ID: 38053091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.
    Li S; Wang X; Zhao Y; Ji W; Mao J; Nie M; Wu X
    Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].
    Jorge AA; Nishi MY; Funari MF; Souza SC; Arnhold IJ; Mendonça BB
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):765-73. PubMed ID: 18797583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SHOX gene and the short stature. Roundtable on diagnosis and treatment of short stature due to SHOX haploinsufficiency: how genetics, radiology and anthropometry can help the pediatrician in the diagnostic process Padova (April 20th, 2011).
    De Sanctis V; Tosetto I; Iughetti L; Antoniazzi F; Clementi M; Toffolutti T; Facchin P; Monti E; Pisanello L; Tonini G; Greggio NA
    Pediatr Endocrinol Rev; 2012 Aug; 9(4):727-33. PubMed ID: 23304810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life long-term efficacy and safety of recombinant human growth hormone therapy in children with short stature homeobox-containing deficiency.
    Bruzzi P; Vannelli S; Scarano E; Di Iorgi N; Parpagnoli M; Salerno M; Pitea M; Elisabeth Street M; Secco A; Andrea Trettene A; Wasniewska M; Corciulo N; Tornese G; Felicia Faienza M; Delvecchio M; Filomena Madeo S; Iughetti L
    Endocr Connect; 2023 Jul; 12(7):. PubMed ID: 37014306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    Xi W; Mao J; Li S; Zhao Y; Nie M; Yu B; Gao Y; Lu L; Wu X
    Endocr Pract; 2020 Sep; 26(9):997-1002. PubMed ID: 33471705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Gonadotropin-Releasing Hormone Analog and a Combination of Gonadotropin-Releasing Hormone Analog and Recombinant Human Growth Hormone on Adult Height in Girls with Early Puberty.
    Hajzadeh G; Ghaemi N; Hadjzadeh MA; Noroozi S; Morovatdar N
    Adv Biomed Res; 2019; 8():57. PubMed ID: 31673530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.